Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion type Assertion NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_head.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion description "[The lower mRNA level of the DAPK-1 gene in tumor and normal tissue from patients with an unfavorable clinical outcome suggests the organ specific loss of tumor suppressor gene expression, predisposing to metastatic tumor disease and shorter overall survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_provenance.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion evidence source_evidence_literature NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_provenance.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion SIO_000772 17945286 NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_provenance.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion wasDerivedFrom befree-20150227 NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_provenance.
- NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_assertion wasGeneratedBy ECO_0000203 NP347417.RAXLJ5MCa7KsJnuZowJWQXjIdTDmvKO_1Y2KE-CKLP-AM130_provenance.